Difference between the abilities of human Fcγ receptor-Expressing CV-1 cells to neutralize American and Asian Genotypes of dengue virus 2

W. W.I.S. Rodrigo; D. C. Alcena; Z. Kou; T. J. Kochel; K. R. Porter; G. Comach; R. C. Rose; X. Jin; J. J. Schlesinger

doi:10.1128/CVI.00363-08

Difference between the abilities of human Fcγ receptor-Expressing CV-1 cells to neutralize American and Asian Genotypes of dengue virus 2

W. W.I.S. Rodrigo, D. C. Alcena, Z. Kou, T. J. Kochel, K. R. Porter, G. Comach, R. C. Rose, X. Jin, J. J. Schlesinger

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

Sera from patients involved in a Peruvian outbreak of dengue virus serotype 1 infection cross-neutralized the American genotype of dengue virus serotype 2 up to 100-fold more efficiently than they did the virulent Asian genotype of dengue virus serotype 2, as determined by a plaque reduction neutralization test (PRNT) with CV-1 fibroblasts modified to express human Fcγ receptor CD32. The concordant preferential immune enhancement of the Asian genotype of dengue virus serotype 2 in human monocytes suggests that such a modification might strengthen the correlation between the PRNT titer and protection.

Original language	English
Pages (from-to)	285-287
Number of pages	3
Journal	Clinical and Vaccine Immunology
Volume	16
Issue number	2
DOIs	https://doi.org/10.1128/CVI.00363-08
State	Published - Feb 2009
Externally published	Yes

Access to Document

10.1128/CVI.00363-08

Cite this

@article{21f317c97f314574bf5789314d3578e4,

title = "Difference between the abilities of human Fcγ receptor-Expressing CV-1 cells to neutralize American and Asian Genotypes of dengue virus 2",

abstract = "Sera from patients involved in a Peruvian outbreak of dengue virus serotype 1 infection cross-neutralized the American genotype of dengue virus serotype 2 up to 100-fold more efficiently than they did the virulent Asian genotype of dengue virus serotype 2, as determined by a plaque reduction neutralization test (PRNT) with CV-1 fibroblasts modified to express human Fcγ receptor CD32. The concordant preferential immune enhancement of the Asian genotype of dengue virus serotype 2 in human monocytes suggests that such a modification might strengthen the correlation between the PRNT titer and protection.",

author = "Rodrigo, {W. W.I.S.} and Alcena, {D. C.} and Z. Kou and Kochel, {T. J.} and Porter, {K. R.} and G. Comach and Rose, {R. C.} and X. Jin and Schlesinger, {J. J.}",

year = "2009",

month = feb,

doi = "10.1128/CVI.00363-08",

language = "English",

volume = "16",

pages = "285--287",

journal = "Clinical and Vaccine Immunology",

issn = "1556-6811",

number = "2",

}

TY - JOUR

T1 - Difference between the abilities of human Fcγ receptor-Expressing CV-1 cells to neutralize American and Asian Genotypes of dengue virus 2

AU - Rodrigo, W. W.I.S.

AU - Alcena, D. C.

AU - Kou, Z.

AU - Kochel, T. J.

AU - Porter, K. R.

AU - Comach, G.

AU - Rose, R. C.

AU - Jin, X.

AU - Schlesinger, J. J.

PY - 2009/2

Y1 - 2009/2

N2 - Sera from patients involved in a Peruvian outbreak of dengue virus serotype 1 infection cross-neutralized the American genotype of dengue virus serotype 2 up to 100-fold more efficiently than they did the virulent Asian genotype of dengue virus serotype 2, as determined by a plaque reduction neutralization test (PRNT) with CV-1 fibroblasts modified to express human Fcγ receptor CD32. The concordant preferential immune enhancement of the Asian genotype of dengue virus serotype 2 in human monocytes suggests that such a modification might strengthen the correlation between the PRNT titer and protection.

AB - Sera from patients involved in a Peruvian outbreak of dengue virus serotype 1 infection cross-neutralized the American genotype of dengue virus serotype 2 up to 100-fold more efficiently than they did the virulent Asian genotype of dengue virus serotype 2, as determined by a plaque reduction neutralization test (PRNT) with CV-1 fibroblasts modified to express human Fcγ receptor CD32. The concordant preferential immune enhancement of the Asian genotype of dengue virus serotype 2 in human monocytes suggests that such a modification might strengthen the correlation between the PRNT titer and protection.

UR - http://www.scopus.com/inward/record.url?scp=59649120284&partnerID=8YFLogxK

U2 - 10.1128/CVI.00363-08

DO - 10.1128/CVI.00363-08

M3 - Article

C2 - 19038781

AN - SCOPUS:59649120284

SN - 1556-6811

VL - 16

SP - 285

EP - 287

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

IS - 2

ER -

Difference between the abilities of human Fcγ receptor-Expressing CV-1 cells to neutralize American and Asian Genotypes of dengue virus 2

Abstract

Access to Document

Fingerprint

Cite this